[Peculiarities of metabolic syndrome and nonalcogolic fatty liver disease in menopausal women].
Correlation between menopause metabolic syndrome and nonalcogolic fatty liver disease (NAFLD) is reviewed. NAFLD refers to a wide spectrum of liver disease ranging from simple fatty liver (steatosis), to nonalcoholic steatohepatitis, to cirrhosis. The causes and pathogenetic factors of the disease are still under investigation. The risk of development of NAFLD during menopause is twice higher in comparison with fertile age and abdominal obesity and insulin resistances is more apparent. This feature is associated with deficit of estrogens during menopause, as risk of development of NAFLD is diminished with substitutive hormonotherapy. The obesity, particularly in the period of menopause, is discussed as additive, independent risk factor of metabolic syndrome and of diseases of hepatobiliare and cardiovascular systems.
N A
NA
Antelava
A V
AV
Antelava
M V
MV
Gongadze
M V
MV
Okudzhava
K Z
KZ
Pachkoriia
M I
MI
Gogolauri
D005234:Fatty Liver / Q000150:complications / Q000473:pathology*; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008103:Liver Cirrhosis / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D008593:Menopause; D024821:Metabolic Syndrome / Q000150:complications / Q000473:pathology*; D065626:Non-alcoholic Fatty Liver Disease; D056128:Obesity, Abdominal / Q000150:complications / Q000473:pathology; D012307:Risk Factors